These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 326847)
21. Spirometric comparison of carbuterol and isoproterenol aerosol therapy in bronchial asthma. A double blind, matched-pair study of 28 adults and a double blind crossover study of 18 children. Rhoades RB; Leifer KN; Bloom FL; Wittig HJ Am Rev Respir Dis; 1976 Jul; 114(1):79-86. PubMed ID: 7174 [TBL] [Abstract][Full Text] [Related]
22. Nebulized atropine sulfate in the treatment of acute asthma. Owens MW; George RB Chest; 1991 May; 99(5):1084-7. PubMed ID: 2019161 [TBL] [Abstract][Full Text] [Related]
23. Metaproterenol solution in the treatment of asthmatic patients by intermittent positive pressure breathing. Branscomb BV J Clin Pharmacol; 1982; 22(5-6):231-5. PubMed ID: 7050188 [TBL] [Abstract][Full Text] [Related]
24. The development of drug tolerance during long-term beta2-agonist bronchodilator therapy. Chervinsky P Chest; 1978 Jun; 73(6 Suppl):1001-2. PubMed ID: 354875 [No Abstract] [Full Text] [Related]
31. Response to inhaled metaproterenol and isoproterenol in asthmatic and normal subjects. Fairshter RD; Wilson AF Chest; 1980 Jul; 78(1):44-50. PubMed ID: 7471844 [TBL] [Abstract][Full Text] [Related]
32. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma. Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901 [TBL] [Abstract][Full Text] [Related]
33. [Hemodynamic effects of common bronchodilator agents following inhalation of aerosols]. Schilling W; Lindenau M Z Erkr Atmungsorgane Folia Bronchol; 1971; 135(3):329-33. PubMed ID: 5211710 [No Abstract] [Full Text] [Related]
34. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease. Friedman M Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715 [TBL] [Abstract][Full Text] [Related]
35. Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma. Choo-Kang YF; Simpson WT; Grant IW Br Med J; 1969 May; 2(5652):287-9. PubMed ID: 4888877 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the acute cardiopulmonary effects of oral albuterol, metaproterenol, and terbutaline in asthmatics. Wolfe JD; Yamate M; Biedermann AA; Chu TJ JAMA; 1985 Apr; 253(14):2068-72. PubMed ID: 3974097 [TBL] [Abstract][Full Text] [Related]
37. The effect of terbutaline in exercise-induced asthma. Morse JL; Jones NL; Anderson GD Am Rev Respir Dis; 1976 Jan; 113(1):89-92. PubMed ID: 1108720 [TBL] [Abstract][Full Text] [Related]
38. Metaproterenol sulfate for asthmatic children with therapeutic serum theophylline concentrations. Kelly HW; Menendez R; Murphy S; Tuttle W Clin Pharm; 1982; 1(1):49-54. PubMed ID: 6764162 [TBL] [Abstract][Full Text] [Related]
39. Comparison of fenoterol and orciprenaline with regard to broncho-dilating action and beta 2-selectivity. Sasaki T; Takishima T; Sugiura R J Int Med Res; 1980; 8(3):205-16. PubMed ID: 6248395 [TBL] [Abstract][Full Text] [Related]
40. Controlled clinical trial of a new dosage form of metaproterenol. Beck GJ Ann Allergy; 1980 Jan; 44(1):19-22. PubMed ID: 6986110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]